These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14499166)

  • 1. Global policy: aspects of diabetes in India.
    Bjork S; Kapur A; King H; Nair J; Ramachandran A
    Health Policy; 2003 Oct; 66(1):61-72. PubMed ID: 14499166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in funding diabetes care: a health economic perspective.
    Weber C
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):517-24. PubMed ID: 20950068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
    McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
    Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040.
    Waldeyer R; Brinks R; Rathmann W; Giani G; Icks A
    Diabet Med; 2013 Aug; 30(8):999-1008. PubMed ID: 23506452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and its complications in India.
    Unnikrishnan R; Anjana RM; Mohan V
    Nat Rev Endocrinol; 2016 Jun; 12(6):357-70. PubMed ID: 27080137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of diabetic patients in India: A review.
    Bansode B; Jungari DS
    Diabetes Metab Syndr; 2019; 13(4):2469-2472. PubMed ID: 31405662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes in Japan: a review of disease burden and approaches to treatment.
    Neville SE; Boye KS; Montgomery WS; Iwamoto K; Okamura M; Hayes RP
    Diabetes Metab Res Rev; 2009 Nov; 25(8):705-16. PubMed ID: 19795421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications.
    Lamri L; Gripiotis E; Ferrario A
    Global Health; 2014 Feb; 10():11. PubMed ID: 24564974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive hospitalizations and its associated economic burden among people with diabetes in the United States.
    Kim S; Boye KS
    Value Health; 2009; 12(2):267-72. PubMed ID: 20667061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar.
    Bener A; Al-Hamaq AO
    Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):504-511. PubMed ID: 27023007
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial.
    O'Brien CL; Ski CF; Thompson DR; Moore G; Mancuso S; Jenkins A; Ward G; MacIsaac RJ; Loh M; Knowles SR; Rossell SL; Castle DJ
    Trials; 2016 Sep; 17(1):444. PubMed ID: 27612943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
    Johnson JA; Pohar SL; Majumdar SR
    Diabetes Care; 2006 Nov; 29(11):2403-8. PubMed ID: 17065675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study.
    Karter AJ; Stevens MR; Herman WH; Ettner S; Marrero DG; Safford MM; Engelgau MM; Curb JD; Brown AF;
    Diabetes Care; 2003 Aug; 26(8):2294-9. PubMed ID: 12882851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of hypoglycemia on healthcare in Spain.
    Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes management: current diagnostic criteria, drug therapies, and state legislation.
    Lyons T; Gourley G; Holt JM
    Am J Manag Care; 1997 Oct; 3(10):1599-608; quiz 1161-4. PubMed ID: 10178463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.